These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5941202)

  • 1. Transamidase activity of the enzyme responsible for insoluble fibrin formation.
    Loewy AG; Matacić S; Darnell JH
    Arch Biochem Biophys; 1966 Feb; 113(2):435-8. PubMed ID: 5941202
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of plasma transamidase activity in congenital deficiency of fibrin stabilizing factor (Factor 13).
    Miloszewski K; Walls WD; Losowsky MS
    Br J Haematol; 1969 Aug; 17(2):159-62. PubMed ID: 5804403
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F; Barbui T
    J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Our ancient heritage in blood clotting and some of its consequences.
    Laki K
    Ann N Y Acad Sci; 1972 Dec; 202():297-307. PubMed ID: 4508929
    [No Abstract]   [Full Text] [Related]  

  • 5. A TRANSAMIDASE MECHANISM FOR INSOLUBLE FIBRIN FORMATION.
    Loewy AG; Dahlberg JE; Dorwart WV; Weber MJ; Eisele J
    Biochem Biophys Res Commun; 1964 Mar; 15(2):177-81. PubMed ID: 26410913
    [No Abstract]   [Full Text] [Related]  

  • 6. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with fibrin stabilization by polymyxin B sulfate.
    Marshall FN; Massad EN
    Proc Soc Exp Biol Med; 1967 Jun; 125(2):420-3. PubMed ID: 4291164
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE FIBRIN-STABILIZING FACTOR].
    GORMSEN J
    Ugeskr Laeger; 1964 Oct; 126():1417-22. PubMed ID: 14240318
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombin-dependent spleen transamidase.
    Zuch A
    Haemostasis; 1980; 9(2):85-91. PubMed ID: 6102074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BEHAVIOR OF FIBRIN STABILIZING FACTOR IN LIVER DISEASES].
    OTTAVIANI P; MANDELLI F; FONTANA L; MORELLI R
    Prog Med (Napoli); 1965 Feb; 21():115-20. PubMed ID: 14340535
    [No Abstract]   [Full Text] [Related]  

  • 11. DEFECTIVE FIBRINASE ACTIVITY IN TWO BROTHERS.
    HAMPTON JW; BIRD RM; HAMMARSTEN DM
    J Lab Clin Med; 1965 Mar; 65():469-74. PubMed ID: 14261328
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis.
    Kłoczko J; Wereszczyńska U; Wojtukiewicz M; Gybryelewicz A; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):539-44. PubMed ID: 2431976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ON THE PLASMA CONTENT OF FIBRIN-STABILIZING FACTOR (FSF) IN VARIOUS LIFE PERIODS].
    STROEDER J
    Klin Wochenschr; 1964 Jul; 42():649-50. PubMed ID: 14248616
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of factor 13 by heparin.
    Green J
    J Clin Pathol; 1968 Nov; 21(6):793. PubMed ID: 5717562
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 17. Desmofibrin formation and the activity of the fibrin stabilizing factor (FSF) during the cleavage of its SH groups by thrombin.
    Buluk K; Olbromski J; Januszko T; Zuch A
    Thromb Diath Haemorrh; 1966 Jul; 16(1):51-60. PubMed ID: 5989050
    [No Abstract]   [Full Text] [Related]  

  • 18. The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
    Shemirani AH; Haramura G; Bagoly Z; Muszbek L
    Biochim Biophys Acta; 2006 Aug; 1764(8):1420-3. PubMed ID: 16920044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin-stabilizing factor inhibitors.
    Nilsson JL; Stenberg P; Ljunggren C; Hoffman KJ; Lundén R; Eriksson O; Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():286-96. PubMed ID: 4508928
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.
    Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():6-30. PubMed ID: 4565370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.